To further investigate whether this upregulation of p16INK4a was reflecting changes in the transcription levels of known regulators of this tumor suppressor, such as Bmi1 15,25, Ezh1 26, Ezh2 27,28, and Suz12 29, we analyzed the expression of these genes by qPCR. This evidence concerns the gene CDKN2A and neoplasm.